WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

OTC Pharmaceuticals in Brazil

Datamonitor, November 2010, Pages: 43

The OTC Pharmaceuticals in Brazil industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

- Contains an executive summary and data on value, volume and/or segmentation

- Provides textual analysis of OTC Pharmaceuticals in Brazil’s recent performance and future prospects

- Incorporates in-depth five forces competitive environment analysis and scorecards

- Includes a five-year forecast of OTC Pharmaceuticals in Brazil

- The leading companies are profiled with supporting key financial metrics

- Supported by the key macroeconomic and demographic data affecting the market

Highlights

- Detailed information is included on market size, measured by both value and volume

- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

- Market shares are covered by manufacturer and/or brand

- Also features market breakdown by distribution channel

Why you should buy this report

- Spot future trends and developments

- Inform your business decisions

- Add weight to presentations and marketing materials

- Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purpose of this report the Americas comprises Argentina, Brazil, Canada, Chile, Colombia, Mexico, Venezuela, and the US.

EXECUTIVE SUMMARY
MARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
MARKET DISTRIBUTION
MARKET FORECASTS
Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting

LIST OF TABLES
Table 1: Brazil OTC pharmaceuticals market value: $ million, 2005–09
Table 2: Brazil OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 3: Brazil OTC pharmaceuticals market segmentation II: % share, by value, 2009
Table 4: Brazil OTC pharmaceuticals market share: % share, by value, 2009
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: key financials ($)
Table 7: Johnson & Johnson: key financial ratios
Table 8: Sanofi-Aventis: key facts
Table 9: Sanofi-Aventis: key financials ($)
Table 10: Sanofi-Aventis: key financials (€)
Table 11: Sanofi-Aventis: key financial ratios
Table 12: Abbott Laboratories: key facts
Table 13: Abbott Laboratories: key financials ($)
Table 14: Abbott Laboratories: key financial ratios
Table 15: Brazil OTC pharmaceuticals market distribution: % share, by value, 2009
Table 16: Brazil OTC pharmaceuticals market value forecast: $ million, 2009–14
Table 17: Brazil size of population (million), 2005–09
Table 18: Brazil gdp (constant 2000 prices, $ billion), 2005–09
Table 19: Brazil gdp (current prices, $ billion), 2005–09
Table 20: Brazil inflation, 2005–09
Table 21: Brazil consumer price index (absolute), 2005–09
Table 22: Brazil exchange rate, 2005–09

LIST OF FIGURES
Figure 1: Brazil OTC pharmaceuticals market value: $ million, 2005–09
Figure 2: Brazil OTC pharmaceuticals market segmentation I:% share, by value, 2009
Figure 3: Brazil OTC pharmaceuticals market segmentation II: % share, by value, 2009
Figure 4: Brazil OTC pharmaceuticals market share: % share, by value, 2009
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Brazil, 2009
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Brazil, 2009
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Brazil, 2009
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Brazil, 2009
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Brazil, 2009
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Brazil, 2009
Figure 11: Johnson & Johnson: revenues & profitability
Figure 12: Johnson & Johnson: assets & liabilities
Figure 13: Sanofi-Aventis: revenues & profitability
Figure 14: Sanofi-Aventis: assets & liabilities
Figure 15: Abbott Laboratories: revenues & profitability
Figure 16: Abbott Laboratories: assets & liabilities
Figure 17: Brazil OTC pharmaceuticals market distribution: % share, by value, 2009
Figure 18: Brazil OTC pharmaceuticals market value forecast: $ million, 2009–14



- GlaxoSmithKline Plc
- Novartis AG
- Pfizer Inc

Customers who bought this item also bought